AI assistant
BIODESIX INC — Director's Dealing 2026
Jan 6, 2026
34472_dirs_2026-01-06_73eb9d02-e7ee-4049-9257-06722160e840.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2026-01-02
Reporting Person: PATIENCE JOHN (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-01-05 | Common Stock | M | 1143 | — | Acquired | 22661 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-01-02 | Restricted Stock Units | $ | A | 5443 | Acquired | Common Stock (5443) | Direct | |
| 2026-01-02 | Stock Options (Right to Buy) | $6.46 | A | 6354 | Acquired | 2036-01-01 | Common Stock (6354) | Direct |
| 2026-01-05 | Restricted Stock Units | $ | M | 1143 | Disposed | Common Stock (1143) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 107664 | Indirect |
| Common Stock | 241480 | Indirect |
| Common Stock | 2649 | Indirect |
Footnotes
F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock ("Common Stock").
F2: The Reporting Person is the sole general partner of Patience Enterprises LP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3: The Reporting Person is the sole trustee of John Patience Living Trust (July 23, 1993).
F4: These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
F5: This option vests in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer.
F6: These RSUs vested in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and had no expiration date.